{"entity":{"type":"insider","cik":"0001620084","url":"/insider/0001620084","json_url":"/insider/0001620084.json","name":"PIMSTONE SIMON N.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":36,"n_filings":9,"first":"2017-08-14","last":"2023-06-01","span_basis":"filed_date"},"name_variants":[{"name":"PIMSTONE SIMON N.","source":"filing","n_filings":9,"first_seen":"2017-08-14","last_seen":"2023-06-01"}],"transactions":[{"id":8724170,"accession":"0000950170-23-025802","txn_seq":15,"anchor":"line-15","filing_url":"/filing/0000950170-23-025802","line_url":"/filing/0000950170-23-025802","is_derivative":false,"issuer_cik":"0001582313","issuer_name":"Xenon Pharmaceuticals Inc.","issuer_ticker":"XENE","issuer_name_source":null,"issuer_url":"/issuer/0001582313","owner_cik":"0001620084","owner_name":"PIMSTONE SIMON N.","owner_display_name":"PIMSTONE SIMON N.","owner_url":"/insider/0001620084","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":31713.0,"shares_display":"31,713","price_per_share":38.82468262226847,"price_display":"38.82","price_state":"stated","total_value":1231247.16,"total_display":"1,231,247.16","total_whole":"1,231,247","shares_owned_after":6000.0,"shares_owned_after_display":"6,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-01","filed_date":"2023-06-01","scope":"insider","n_lines":2},{"id":8724157,"accession":"0000950170-23-025802","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0000950170-23-025802","line_url":"/filing/0000950170-23-025802","is_derivative":false,"issuer_cik":"0001582313","issuer_name":"Xenon Pharmaceuticals Inc.","issuer_ticker":"XENE","issuer_name_source":null,"issuer_url":"/issuer/0001582313","owner_cik":"0001620084","owner_name":"PIMSTONE SIMON N.","owner_display_name":"PIMSTONE SIMON N.","owner_url":"/insider/0001620084","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":62526.0,"shares_display":"62,526","price_per_share":38.70472027636503,"price_display":"38.70","price_state":"stated","total_value":2420051.34,"total_display":"2,420,051.34","total_whole":"2,420,051","shares_owned_after":6000.0,"shares_owned_after_display":"6,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-31","filed_date":"2023-06-01","scope":"insider","n_lines":3},{"id":8724145,"accession":"0000950170-23-025802","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-23-025802","line_url":"/filing/0000950170-23-025802","is_derivative":false,"issuer_cik":"0001582313","issuer_name":"Xenon Pharmaceuticals Inc.","issuer_ticker":"XENE","issuer_name_source":null,"issuer_url":"/issuer/0001582313","owner_cik":"0001620084","owner_name":"PIMSTONE SIMON N.","owner_display_name":"PIMSTONE SIMON N.","owner_url":"/insider/0001620084","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":37006.0,"shares_display":"37,006","price_per_share":39.28205642328271,"price_display":"39.28","price_state":"stated","total_value":1453671.78,"total_display":"1,453,671.78","total_whole":"1,453,672","shares_owned_after":18000.0,"shares_owned_after_display":"18,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-30","filed_date":"2023-06-01","scope":"insider","n_lines":2},{"id":8437230,"accession":"0001209191-23-017636","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-23-017636","line_url":"/filing/0001209191-23-017636","is_derivative":false,"issuer_cik":"0001582313","issuer_name":"Xenon Pharmaceuticals Inc.","issuer_ticker":"XENE","issuer_name_source":null,"issuer_url":"/issuer/0001582313","owner_cik":"0001620084","owner_name":"PIMSTONE SIMON N.","owner_display_name":"PIMSTONE SIMON N.","owner_url":"/insider/0001620084","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19232.0,"shares_display":"19,232","price_per_share":36.98000103993344,"price_display":"36.98","price_state":"stated","total_value":711199.38,"total_display":"711,199.38","total_whole":"711,199","shares_owned_after":34002.0,"shares_owned_after_display":"34,002","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-07","filed_date":"2023-03-09","scope":"insider","n_lines":2},{"id":6374021,"accession":"0001209191-22-046015","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-22-046015","line_url":"/filing/0001209191-22-046015","is_derivative":false,"issuer_cik":"0001582313","issuer_name":"Xenon Pharmaceuticals Inc.","issuer_ticker":"XENE","issuer_name_source":null,"issuer_url":"/issuer/0001582313","owner_cik":"0001620084","owner_name":"PIMSTONE SIMON N.","owner_display_name":"PIMSTONE SIMON N.","owner_url":"/insider/0001620084","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":52058.0,"shares_display":"52,058","price_per_share":38.51282838372585,"price_display":"38.51","price_state":"stated","total_value":2004900.82,"total_display":"2,004,900.82","total_whole":"2,004,901","shares_owned_after":26000.0,"shares_owned_after_display":"26,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-16","filed_date":"2022-08-16","scope":"insider","n_lines":2},{"id":6374015,"accession":"0001209191-22-046015","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-22-046015","line_url":"/filing/0001209191-22-046015#line-4","is_derivative":false,"issuer_cik":"0001582313","issuer_name":"Xenon Pharmaceuticals Inc.","issuer_ticker":"XENE","issuer_name_source":null,"issuer_url":"/issuer/0001582313","owner_cik":"0001620084","owner_name":"PIMSTONE SIMON N.","owner_display_name":"PIMSTONE SIMON N.","owner_url":"/insider/0001620084","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":33942.0,"shares_display":"33,942","price_per_share":37.76,"price_display":"37.76","price_state":"stated","total_value":1281649.92,"total_display":"1,281,649.92","total_whole":"1,281,650","shares_owned_after":58058.0,"shares_owned_after_display":"58,058","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-15","filed_date":"2022-08-16","scope":"insider"},{"id":6374012,"accession":"0001209191-22-046015","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-22-046015","line_url":"/filing/0001209191-22-046015","is_derivative":false,"issuer_cik":"0001582313","issuer_name":"Xenon Pharmaceuticals Inc.","issuer_ticker":"XENE","issuer_name_source":null,"issuer_url":"/issuer/0001582313","owner_cik":"0001620084","owner_name":"PIMSTONE SIMON N.","owner_display_name":"PIMSTONE SIMON N.","owner_url":"/insider/0001620084","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":91135.0,"shares_display":"91,135","price_per_share":38.279451911998684,"price_display":"38.28","price_state":"stated","total_value":3488597.85,"total_display":"3,488,597.85","total_whole":"3,488,598","shares_owned_after":93000.0,"shares_owned_after_display":"93,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-12","filed_date":"2022-08-16","scope":"insider","n_lines":3},{"id":9271684,"accession":"0001209191-22-017418","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-017418","line_url":"/filing/0001209191-22-017418#line-1","is_derivative":false,"issuer_cik":"0001582313","issuer_name":"Xenon Pharmaceuticals Inc.","issuer_ticker":"XENE","issuer_name_source":null,"issuer_url":"/issuer/0001582313","owner_cik":"0001620084","owner_name":"PIMSTONE SIMON N.","owner_display_name":"PIMSTONE SIMON N.","owner_url":"/insider/0001620084","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":30.8,"price_display":"30.80","price_state":"stated","total_value":77000.0,"total_display":"77,000.00","total_whole":"77,000","shares_owned_after":193135.0,"shares_owned_after_display":"193,135","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-08","filed_date":"2022-03-08","scope":"insider"},{"id":6143980,"accession":"0001209191-22-017341","txn_seq":19,"anchor":"line-19","filing_url":"/filing/0001209191-22-017341","line_url":"/filing/0001209191-22-017341","is_derivative":false,"issuer_cik":"0001582313","issuer_name":"Xenon Pharmaceuticals Inc.","issuer_ticker":"XENE","issuer_name_source":null,"issuer_url":"/issuer/0001582313","owner_cik":"0001620084","owner_name":"PIMSTONE SIMON N.","owner_display_name":"PIMSTONE SIMON N.","owner_url":"/insider/0001620084","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14551.0,"shares_display":"14,551","price_per_share":25.815105491031545,"price_display":"25.82","price_state":"stated","total_value":375635.6,"total_display":"375,635.60","total_whole":"375,636","shares_owned_after":185635.0,"shares_owned_after_display":"185,635","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-08","filed_date":"2022-03-08","scope":"insider","n_lines":6},{"id":6143962,"accession":"0001209191-22-017341","txn_seq":13,"anchor":"line-13","filing_url":"/filing/0001209191-22-017341","line_url":"/filing/0001209191-22-017341","is_derivative":false,"issuer_cik":"0001582313","issuer_name":"Xenon Pharmaceuticals Inc.","issuer_ticker":"XENE","issuer_name_source":null,"issuer_url":"/issuer/0001582313","owner_cik":"0001620084","owner_name":"PIMSTONE SIMON N.","owner_display_name":"PIMSTONE SIMON N.","owner_url":"/insider/0001620084","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":31086.0,"shares_display":"31,086","price_per_share":30.504399729781895,"price_display":"30.50","price_state":"stated","total_value":948259.77,"total_display":"948,259.77","total_whole":"948,260","shares_owned_after":200186.0,"shares_owned_after_display":"200,186","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-07","filed_date":"2022-03-08","scope":"insider","n_lines":7},{"id":6143935,"accession":"0001209191-22-017341","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-22-017341","line_url":"/filing/0001209191-22-017341","is_derivative":false,"issuer_cik":"0001582313","issuer_name":"Xenon Pharmaceuticals Inc.","issuer_ticker":"XENE","issuer_name_source":null,"issuer_url":"/issuer/0001582313","owner_cik":"0001620084","owner_name":"PIMSTONE SIMON N.","owner_display_name":"PIMSTONE SIMON N.","owner_url":"/insider/0001620084","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9325.0,"shares_display":"9,325","price_per_share":30.60860053619303,"price_display":"30.61","price_state":"stated","total_value":285425.2,"total_display":"285,425.20","total_whole":"285,425","shares_owned_after":210186.0,"shares_owned_after_display":"210,186","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-04","filed_date":"2022-03-08","scope":"insider","n_lines":2},{"id":5384994,"accession":"0001209191-21-064931","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-064931","line_url":"/filing/0001209191-21-064931#line-1","is_derivative":false,"issuer_cik":"0001582313","issuer_name":"Xenon Pharmaceuticals Inc.","issuer_ticker":"XENE","issuer_name_source":null,"issuer_url":"/issuer/0001582313","owner_cik":"0001620084","owner_name":"PIMSTONE SIMON N.","owner_display_name":"PIMSTONE SIMON N.","owner_url":"/insider/0001620084","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17557.0,"shares_display":"17,557","price_per_share":31.33,"price_display":"31.33","price_state":"stated","total_value":550060.81,"total_display":"550,060.81","total_whole":"550,061","shares_owned_after":210186.0,"shares_owned_after_display":"210,186","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-15","filed_date":"2021-11-16","scope":"insider"},{"id":2730361,"accession":"0001209191-20-033578","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-033578","line_url":"/filing/0001209191-20-033578#line-2","is_derivative":false,"issuer_cik":"0001582313","issuer_name":"Xenon Pharmaceuticals Inc.","issuer_ticker":"XENE","issuer_name_source":null,"issuer_url":"/issuer/0001582313","owner_cik":"0001620084","owner_name":"PIMSTONE SIMON N.","owner_display_name":"PIMSTONE SIMON N.","owner_url":"/insider/0001620084","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":14.43,"price_display":"14.43","price_state":"stated","total_value":43290.0,"total_display":"43,290.00","total_whole":"43,290","shares_owned_after":255186.0,"shares_owned_after_display":"255,186","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-01","filed_date":"2020-06-02","scope":"insider"},{"id":2730357,"accession":"0001209191-20-033578","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-033578","line_url":"/filing/0001209191-20-033578#line-1","is_derivative":false,"issuer_cik":"0001582313","issuer_name":"Xenon Pharmaceuticals Inc.","issuer_ticker":"XENE","issuer_name_source":null,"issuer_url":"/issuer/0001582313","owner_cik":"0001620084","owner_name":"PIMSTONE SIMON N.","owner_display_name":"PIMSTONE SIMON N.","owner_url":"/insider/0001620084","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":13.99,"price_display":"13.99","price_state":"stated","total_value":69950.0,"total_display":"69,950.00","total_whole":"69,950","shares_owned_after":258186.0,"shares_owned_after_display":"258,186","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-29","filed_date":"2020-06-02","scope":"insider"},{"id":8396320,"accession":"0001209191-19-050588","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-050588","line_url":"/filing/0001209191-19-050588#line-1","is_derivative":false,"issuer_cik":"0001582313","issuer_name":"Xenon Pharmaceuticals Inc.","issuer_ticker":"XENE","issuer_name_source":null,"issuer_url":"/issuer/0001582313","owner_cik":"0001620084","owner_name":"PIMSTONE SIMON N.","owner_display_name":"PIMSTONE SIMON N.","owner_url":"/insider/0001620084","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10395.0,"shares_display":"10,395","price_per_share":9.51,"price_display":"9.51","price_state":"stated","total_value":98856.45,"total_display":"98,856.45","total_whole":"98,856","shares_owned_after":258122.0,"shares_owned_after_display":"258,122","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-09-20","filed_date":"2019-09-24","scope":"insider"},{"id":4866796,"accession":"0001171843-17-005069","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001171843-17-005069","line_url":"/filing/0001171843-17-005069#line-1","is_derivative":false,"issuer_cik":"0001582313","issuer_name":"Xenon Pharmaceuticals Inc.","issuer_ticker":"XENE","issuer_name_source":null,"issuer_url":"/issuer/0001582313","owner_cik":"0001620084","owner_name":"PIMSTONE SIMON N.","owner_display_name":"PIMSTONE SIMON N.","owner_url":"/insider/0001620084","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6000.0,"shares_display":"6,000","price_per_share":2.9,"price_display":"2.90","price_state":"stated","total_value":17400.0,"total_display":"17,400.00","total_whole":"17,400","shares_owned_after":217847.0,"shares_owned_after_display":"217,847","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-08-10","filed_date":"2017-08-14","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":36,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":35,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":36},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001582313","name":"Xenon Pharmaceuticals Inc.","url":"/issuer/0001582313","role":"Director, Officer (CEO)","n_filings":9,"first_seen":"2017-08-14","last_seen":"2023-06-01"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001620084","retrieved_at":"2026-08-25T14:38:20+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}